Medical Dialogues
  • Dermatology
Sign in Signup
This site is intended for healthcare professionals only
Sign in Signup
  • Medical Jobs
  • Medical Matrimony
  • MD Brand Connect
  • MDTV
Medical Dialogues
  • Medical News
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Medical Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
  • MDTV
      • Anesthesia
      • CTVS
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • Diet and nutrition
      • ENT
      • Gastroenterology
      • Health Dialogues
      • Health News today
      • Health Shorts
      • Health Updates
      • Health video of the day
      • Laboratory Medicine
      • Latest Videos
      • Latest Webinars
      • MD shorts
      • Medical News Today
      • Medical Updates
      • Medical Video of the day
      • Medicine
      • Nephrology
      • Neurology and Neurosurgery
      • Obstetrics and Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics & Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Top Videos
      • Urology
This site is intended for healthcare professionals only
Sign InRegister
Medical Dialogues
Sign inRegister
  • Home
  • Medical news
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Medical Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
  • Case of the Day
  • Editorial
  • Home
  • Pediatrics and Neonatology
  • Pediatrics and Neonatology News
  • Early Tamiflu...

Early Tamiflu administration reduces risk of Flu associated pneumonia in children

MedhaBy MedhaPublished On 2020-02-04T15:08:25+05:30  |  Updated On 4 Feb 2020 9:38 AM GMT
Early Tamiflu administration reduces risk of Flu associated pneumonia in children

China: Early administration of oseltamivir (within the first 48 hours of onset) can reduce the risk of influenza B virus-associated pneumonia in hospitalized pediatric patients, a recent study in the Pediatric Infectious Disease Journal has suggested.Influenza B outbreaks occurred worldwide from November 2017 to April 2018. Annual seasonal influenza epidemics -- caused by influenza virus A and...

China: Early administration of oseltamivir (within the first 48 hours of onset) can reduce the risk of influenza B virus-associated pneumonia in hospitalized pediatric patients, a recent study in the Pediatric Infectious Disease Journal has suggested.

Influenza B outbreaks occurred worldwide from November 2017 to April 2018. Annual seasonal influenza epidemics -- caused by influenza virus A and B -- are associated with enormous health and economic consequences worldwide. It is estimated to cause about 3–5 million cases of serious diseases, and about 250–500,000 deaths each year. 22%–44% of deaths between 2004 and 2011, each season among US pediatric influenza were confirmed to be related with influenza B -- among which 35% were complicated with pneumonia. However, there is limited data on the risk factors for influenza B virus-associated pneumonia in pediatric patients. Identification of risk factors for susceptibility to pneumonia and diagnosis will aid in the early treatment of the disease which in turn will reduce the incidence and mortality rate of pneumonia. 

Zhichu Dai, Department of Accident and Emergency, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China, and colleagues conducted a retrospective study of pediatric patients who had been diagnosed with influenza B infection from November 1, 2017, to April 1, 2018, to investigate demographics, clinical characteristics and laboratory findings and to determine the risk factors of influenza B virus-associated pneumonia.

the rate of age group (0–4 years) received oseltamivir within the first 48 hours of onset (P = 0.002), and the rate of age group (5–9 years) received oseltamivir within the first 48 hours of onset (P = 0.014) than the non-pneumonia group. 

Between November 1, 2017, and April 1, 2018, a total of 275 patients with influenza B virus infection were hospitalized and monitored. Only 215 patients have complete data, of which 78 patients were adults and 137 patients were <18 years of age. 

Key findings of the study include:

· 54 patients (39.4%) with pneumonia were identified.

· No patients died in the period of hospitalization.

· Patients with pneumonia had significant in the day from the onset of symptoms to the emergency department, the rate of received oseltamivir within the first 48 hours of onset.

· The pneumonia group was also significantly higher rate of frequent cough, a higher level of serum CRP.

· No significant difference was observed in the rate of gender, age group, underlying conditions, use of antibiotics before admission and the recent injection of influenza vaccine between the 2 groups.

· BMI, age, symptoms, dose of oseltamivir use per body weight within the first 48 hours of onset and other laboratories findings, except serum CRP level, were similar in both groups.

"In conclusion, received oseltamivir within the first 48 hours of onset was a protective factor, while frequent cough was a risk factor for the influenza B virus-associated pneumonia in hospitalized pediatric patients," wrote the authors.

The study, "Early Administration of Oseltamivir Within 48 Hours After Onset of Flulike Symptoms Can Reduce the Risk of Influenza B Virus-Associated Pneumonia in Hospitalized Pediatric Patients with Influenza B Virus Infection," is published in the Pediatric Infectious Disease Journal. 

DOI: 10.1097/INF.0000000000002528

pneumonia influenza B Pediatric Infectious Disease Journal oseltamivir Tamiflu 
Source : Pediatric Infectious Disease Journal
Medha
Medha

    Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story
    Similar Posts
    NO DATA FOUND

    Editorial

    Treatment challenges in managing Gastroparesis related to PPI Use: Analyzing scope of Probiotics

    Treatment challenges in managing Gastroparesis related to PPI Use: Analyzing scope of Probiotics

    Review: Efficacy of Antiviral Agents Against  Omicron Subvariant BA.2

    Review: Efficacy of Antiviral Agents Against Omicron Subvariant BA.2

    Choice of Antibiotics in Common Infections: Doxycycline or Azithromycin?

    Choice of Antibiotics in Common Infections: Doxycycline or Azithromycin?

    Role of acyclovir in Management of chickenpox: Analyzing the importance of starting early

    Role of acyclovir in Management of chickenpox: Analyzing the importance of starting early

    Parkinsonism and the place of Amantadine - Review Analysis

    Parkinsonism and the place of Amantadine - Review Analysis

    View All

    Journal Club Today

    Twincretin Tirzepatide Recieves FDA Approval for Type 2 Diabetes

    'Twincretin' Tirzepatide Recieves FDA Approval for Type 2 Diabetes

    View All

    Health News Today

    Health Bulletin 17/May/2022

    Health Bulletin 17/May/2022

    View All
    © 2019 All Rights Reserved.
    Powered By: Hocalwire
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
    X
    X